Goldman Small Cap Research

Goldman Small Cap Research We publish sponsored small cap research reports, interviews, market newsletters, and podcasts.

We publish sponsored microcap research and independent small cap, stock market, and ETF trading and investing ideas via blogs and newsletters. Perform your due diligence and refer to disclosures on our website before investing in any securities featured or profiled on this page.

AI stocks are the hottest segment of the market and for good reason. A new report is out today on an under the radar AI ...
08/24/2023

AI stocks are the hottest segment of the market and for good reason. A new report is out today on an under the radar AI firm abt to surge higher as well. Sybleu (Ticker: SYBE) is an AI-driven drug discovery firm in the lucrative vet health market. This industry segment has peers that boast huge valuations ranging from 27x - 100x revenue---and it looks like SYBE is on the same path as it reaches a series of milestones in the coming months. Investors have an insatiable appetite for these stocks and continue to raise hundreds of millions for them. That is why we believe SYBE could join the party by year-end.

Emerging AI-Driven Biotech Sybleu, Inc. (OTC:SYBE) offers competitive advantages and upcoming milestones in the stock market's top-followed and funded segment, AI, prompting a potential surge in the s

PUR Biologics, the primary medtech subsidiary of HippoFi, Inc. (Ticker: ORHB) is hitting the ball out of the park. In ju...
08/17/2023

PUR Biologics, the primary medtech subsidiary of HippoFi, Inc. (Ticker: ORHB) is hitting the ball out of the park. In just the past few months, the company had its biologics products used in spinal surgeries for bone regeneration approved for use in the entire VA health network---that's 171 medical centers and 1,113 outpatient sites serving millions of veterans. Plus, military bases. ORHB has also signed a deal to join forces w/an industry giant, introduced new products, and was awarded 2 new breakthrough patents. The stock appears to be a great entry point as the outcomes of these events should result in major price gains.

In what may be the best kept secret on Wall Street, emerging MedTech Firm HippoFi, Inc. (OTC:ORHB) is experiencing unprecedented sales growth. And that's just part of this innovator's story.

New report on award-winning smart gym equip maker and digital health services co. Interactive Strength, Inc. d/b/a FORME...
08/17/2023

New report on award-winning smart gym equip maker and digital health services co. Interactive Strength, Inc. d/b/a FORME (NASDAQ: TRNR). Co. just signed an LOI for an acquisition that we believe is transformative for TRNR. It will dramatically accelerate high rev growth/profit. Thus, the deal could lead to major stock gains ahead. TRNR closed @ $1.23, trades only 0.7x sales--artificially low valuation. Now a great entry point. Our target is $4.15, and reflects a reasonable 3x 2024E sales.

Interactive Strength, Inc. (NASDAQ: TRNR) d/b/a FORME is about to make a profound change in its business that will prompt major growth, accelerate profit, and drive the artificially low valuation subs

We have published new report out on The Healing Company (Ticker: HLCO), the next health and wellness unicorn. HLCO has a...
08/14/2023

We have published new report out on The Healing Company (Ticker: HLCO), the next health and wellness unicorn. HLCO has a strong relationship with Deepak Chopra, who is the Chief Scientific Officer. The company also owns and operates Chopra Global which boasts a huge following, especially on social media. There are a series of acq deals ahead & a $150M M&A credit facility to draw down on which are poised to drive major sales growth. Plus, a NASDAQ uplisting in the cards. We currently have a $9 tgt price.

Leveraging a $150M M&A-targeted credit facility, and a core relationship with Deepak Chopra, integrated health firm The Healing Company, Inc. (OTCQB: HLCO) is poised to record exponential revenue grow

New report on a company undergoing a major transformation--driving annual rev growth from $162M in 2022 to $913M in 2023...
05/05/2023

New report on a company undergoing a major transformation--driving annual rev growth from $162M in 2022 to $913M in 2023, with $0.30 in adjusted EPS. Muscle Maker Inc. (NASDAQ:GRIL) is fast becoming a major player in the global food supply chain, with 2 distinct business lines. Our 6-9 month conservative target is 3x recent prices, with more potential upside in the cards. Given its rapid transformation, and huge growth, GRIL could be the most talked about play on NASDAQ this year.

Muscle Maker, Inc. (NASDAQ: GRIL) is set to grow revenue from $162M in 2022 to over $1B in 2024, with a substantial rise in adjusted net income, thereby driving its share price to new highs

ICYMI...HippoFi, Inc. (ORHB) was one of the biggest movers in the stock market last week, right after we issued our repo...
04/24/2023

ICYMI...HippoFi, Inc. (ORHB) was one of the biggest movers in the stock market last week, right after we issued our report on the company. ORHB is a fast-growing, underfollowed medtech company that offers considerable upside. Check it out here:

In what may be the best kept secret on Wall Street, emerging MedTech Firm HippoFi, Inc. (OTC:ORHB) is experiencing unprecedented sales growth. And that's just part of this innovator's story.

Wall Street's best kept secret!We have just published a new report on  HippoFi, Inc. (ORHB). It is an undervalued, under...
04/20/2023

Wall Street's best kept secret!

We have just published a new report on HippoFi, Inc. (ORHB). It is an undervalued, underfollowed medtech provider that is experiencing unprecedented sales growth. This innovative company offers major upside, based on the values placed on its lower growth peers. As word gets out, and upcoming financials are released, we would not be surprised to see aggressive accumulation.

In what may be the best kept secret on Wall Street, emerging MedTech Firm HippoFi, Inc. (OTC:ORHB) is experiencing unprecedented sales growth. And that's just part of this innovator's story.

04/13/2023

We have a new report on fast-growing consumer disc stock Charlie's Holdings (CHUC). The company is very undervalued compared to its slower-growth, larger peers--a gap we believe will narrow this year given that sales could jump by more than 60%, from $26.5M to $44M along with a potentially strong income performance. Our near term target price is 3x higher than the previous close. Check it out here: https://bit.ly/3GF18V5

Good morning! We have an exciting new report our today on Camber Energy, Inc.: CEI on the NYSE. CEI may be the most dive...
03/28/2023

Good morning! We have an exciting new report our today on Camber Energy, Inc.: CEI on the NYSE. CEI may be the most diversified energy and power generation technology stock we've seen in some time. This undervalued co is set to close a merger with Viking Energy Group (VKIN) in 2H23 that serves as a catalyst to drive the combined companies' sales and CEI markedly higher. Check it out here:

The Camber Energy, Inc. (NYSE: CEI) pending merger with Viking Energy Group Inc. (OTC:VKIN) could drive CEI's market cap much higher as the combined company would emerge as one of the most diverse ene

A 3/22/23 online presentation at the Emerging Growth conference could have a nice impact on innovative cancer biotech QS...
03/22/2023

A 3/22/23 online presentation at the Emerging Growth conference could have a nice impact on innovative cancer biotech QSAM Biosciences (OTC:QSAM), where it will present updated clinical trial info. Check it out here: https://yhoo.it/3ncWGpG and check out our price target and recent report here: https://bit.ly/3kFfnRV

QSAM Biosciences, Inc. (OTCQB: QSAM) is a rare biotech. Here are ten reasons why we believe the stock is poised to enjoy significant upside ahead.

Looking forward to the start of March Madness? Look no further...we just posted a great interview with the leaders of Wi...
03/16/2023

Looking forward to the start of March Madness? Look no further...we just posted a great interview with the leaders of Winners Inc. (OTC:WNRS), that features the king of Vegas handicapping and its leading golf handicapper. We discuss how college sports and golf have evolved so much so fast that bettors are seeking insights and guidance from pros like Winners at an ever-increasing rate. Plus, the team gives some picks for March Madness and the Master's Tournament. Recent company news also serve as great wins for the stock. Enjoy the video---it's a lot of fun!

03/16/2023

The Silicon Valley Bank debacle has caused major downturns in the market. We identify who is really at fault, what to expect next, and how to play this phenomenon which is just beginning. https://www.youtube.com/watch?v=rjgIrR4YN2U&t=600s

03/01/2023

Clinical stage biotech company QSAM Biosciences, Inc. (OTCQB: QSAM: $4.31) is on a swift dev path that could potentially lead to an investment or acquisition by Big Pharma in 24-36 mos which is the norm for the space, given what has happened to its peers. Plus, mgmt has a deep history of FDA drug and device approvals and exits. Check out the new report on QSAM. https://bit.ly/3kFfnRV

This week we answer some key questions. What has been driving the stock market higher this year, and will it continue? H...
02/21/2023

This week we answer some key questions. What has been driving the stock market higher this year, and will it continue? How will retail perform? Also, see why some very interesting moves on the ETF front has us considering a most unusual, but potentially profitable play. Are you a fan of Under Armour (NASDAQ:UA) the stock? Check out our high level views. All this and more in the latest edition of The Goldman Guide.

Goldman Small Cap Research has produced timely, actionable, research reports, blogs, and newsletters on publicly-traded emerging growth stocks, microcaps and penny stocks, along with insightful market commentary.

I am sure you have all noticed the news reports of the US military shooting down unidentified flying objects, or unmanne...
02/13/2023

I am sure you have all noticed the news reports of the US military shooting down unidentified flying objects, or unmanned aerial systems over the US over the past week. This could be a new trend. For our latest edition of The Goldman Guide, we dug deep and found a NASDAQ defense company that specializes in space sensing and short range air defense. Space sensing is a fast-growing segment of the military that refers to systems that monitor low earth orbit satellites, hypersonic missiles and other equipment. Seems like a great way to play this current trend as the US could ramp up and broadly deploy it. For more info check out the latest edition of the Guide where we also declare a winter for the stock market and what you should do, ahead of it.

New report out today on Winners, Inc. (OTC:WNRS). It is a great time for sports gambling stocks as it is just before the...
02/09/2023

New report out today on Winners, Inc. (OTC:WNRS). It is a great time for sports gambling stocks as it is just before the Super Bowl where a record amt of Americans and funds will be bet. WNRS is our top upside play in the space and it is led by the King of Vegas gambling. Co. has a great model w/ multiple rev streams. Major growth ahead and WNRS could ultimately be a future M&A target. https://bit.ly/3JY198T

Our latest quick missive provides interesting insights on the former FAANG stocks---Meta (Facebook), Amazon, Apple, Netf...
02/07/2023

Our latest quick missive provides interesting insights on the former FAANG stocks---Meta (Facebook), Amazon, Apple, Netflix, and Alphabet (Google) in side-by-side comparisons---and which one(s) we like and don't like. Plus we introduce Vanda Pharma (NASDAQ: VNDA), a biotech value play w/huge cash position and a bigtime late stage pipeline to go with its FDA approved drugs currently for sale.

Hello. We have published a new report today on KwikClick (OTC:KWIK). The company's disruptive platform is already starti...
02/02/2023

Hello. We have published a new report today on KwikClick (OTC:KWIK). The company's disruptive platform is already starting to change the ecommerce ecosystem. Brands get better ROI, loyalty, save $. Influencers, buyers easily become brand ambassadors and make 2-4x typical commissions, including when a follower. How? Affiliate marketers or influencers generate income when a follower clicks a direct link and if the follower chooses to become an influencer and converts a fellow follower, he/she gets paid as well. This path continues as long as that link is utilized by additional followers. Given this model, our forecasts project that exponential sales growth lies ahead

Address

Baltimore, MD

Alerts

Be the first to know and let us send you an email when Goldman Small Cap Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Goldman Small Cap Research:

Share